期刊文献+

终末期肾病血液透析患者危险因素分析 被引量:2

Risk factors for patients with end stage renal disease undergoing hemodialysis
下载PDF
导出
摘要 目的:探讨影响终末期肾病(ESRD)血液透析患者生活质量及长期存活的各种危险因素及防治方法。方法:选择42例终末期糖尿病肾病血透患者和同期50例相同年龄段非糖尿病血透患者,分别观察死亡原因、存活率、并发症及血生化改变。结果:①糖尿病肾病组1年和2年存活率分别为81%和71%。主要死因是心血管病变,其次是感染。②首次透析时的肌酐值与病死率成正比。③影响透析效果的主要并发症是心血管病变(86%)、高血压(88%)、透析低血压(31%)、感染(50%),与非糖尿病肾病组比较有显著性差异。结论:糖尿病肾病终末期患者较非糖尿病患者应更早进行血透,控制两次透析期间的体重增加<2.5kg,减少透析时血糖波动,防治并发症是减少危险因素,提高存活率及生活质量的关键。 Objective To investigate the risk factors that influence the quality of life and long -term survival of the end stage renal disease (ESRD) patients undergoing hemodialysis, as well as the prophylactic measures. Method We selected ESRD patients with diabetic nephropathy ( DN ) undergoing hemodialysis ( n = 42 ) and those ESRD without DN ( n = 50 ) with similar age distribution. The cause of death,survival rate,complications and the blood biochemistry values changes were observed. Results (1)The survival rate of the patients with DN in the first and second years was 81% and 71% , respectively. The first cause of death was cardiovascular events, and the second was infections. (2)The initial level of serum creatinine was positively related to mortality. (3)The main complications that influenced the outcome of dialysis in patients with DN were cardiovascular diseases (86%), hypertension (88%) ,intradialytie hypotension (31%) and infections (50%). There were significant differences between the patients with DN and those without DN. Conclusion In order to decrease the risk factors and improve the quality of life and long - term survival rate of the ESRD patients caused by DN, it is very important to start hemodialysis earlier than those without DN. The interdialytic weight gain should be controlled within 2. 5kg, and maintain a good intradialytic glueomie control, the complications should be prevented and treated. Key Words :
机构地区 吉林省人民医院
出处 《吉林医学》 CAS 2009年第17期1885-1887,共3页 Jilin Medical Journal
关键词 终末期肾病 糖尿病肾病 血液透析 危险因素 End stage renal disease Diabetic nephropathy Hemodialysis Risk factors
  • 相关文献

参考文献6

  • 1Bommer J. Attaining long - term survival when treating diabetic patients with ESRD by hemodialysis [ J ]. Adv Ren Replace Ther,2001,8 ( 1 ) : 13.
  • 2左力,王梅,王海燕.部分肾科医生在慢性肾脏病诊断和治疗领域中的工作概况[J].中华肾脏病杂志,2005,21(3):127-132. 被引量:30
  • 3Biesenhach G,Hubmann R, Janko O,et al. Predialysis management and predictors for early mortality in uremic patients who die within one year after initiation of dialysis [ J ]. Renal Failure, 2002,24 : 1972.
  • 4Kimmel PL, Varela MP, Peterson RA, et al. Interdialytic weight gain and survival in hemodialysis patients : effects of duration of ESRD and diabetes mellitus [ J ]. Kidney Int, 2000,57 ( 3 ) : 1141.
  • 5Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis [ J ]. Diabetes Care,2001,24(5 ) :909.
  • 6Biesenbach G, Debska - Slizien A, Zazgomik J. Nutritional status in type 2 diabetic patients requiring haemodialysis [J]. Nephrol Dial Transplant, 1999,14 ( 3 ) :655.

二级参考文献12

  • 1Jacobs C, Horl WH, Macdougall IC, et al. European Best Practice Guideline 5:target hemoglobin. Nephrol Dial Transplant,2000,15 Suppl 4: 15-19.
  • 2Valdrrabano F, Horl WH, Maedougall IC, et al. Pre-dialysis survey on anemia management. Nephrol Dial Transplant, 2003,18:89-100.
  • 3National Kidney Foundation. 2001 annual report: ESRD clinical performance measurees project. Am J Kidney Dis ,2002,39 Suppl 2: S20-S56.
  • 4Kim J, Pisoni RL, Danese M, et al. Achievement of proposed NKF-K/DOQI bone metabolism and disease guidelines: results from the dialysis outcomes and practice patterns study(DOPPS).American Society of Nephrology 2003 Renal Week.November 12-17.
  • 5Raggi P, Boulay A, Scott CT, et al. Caediac calcification in adult hemodialysis patients: link between end-stage renal disease and cardiovascular disease? J Am Coil Cardiol, 2002,39:695-701.
  • 6National Kidney Foundation. Clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Am J Kidney Dis,2002,39 Suppl 1: S1-S266.
  • 7左力 陈育青 苏涛 译 见:王海燕 王梅 左力 译.NKF-K/DOQI慢性肾脏病临床实践指南(评估、分期和危险因素分层)[A].见:王海燕,王梅,左力,译.慢性肾脏病及透析的临床实践指南[C].北京:人民卫生出版社,2003.3-274.
  • 8Levey AS, Bosch JP, Levis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med, 1999,130: 461-470.
  • 9Lewis J, Agodoa L, Cheek D, et al. Comparison of crosssectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis,2001,38:744-753.
  • 10周玉红 左力 王梅.MORD方程预测肾小球滤过率的临床应用评价[J].中华肾脏病杂志,2004,20:30-34.

共引文献29

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部